We are live on ! Find out more
GNCA

Genocea Biosciences, Inc.
GNCA

Delisted

GNCA was delisted on the 2nd of June, 2022.

Back to rankings

54 hedge funds and large institutions have $44.5M invested in Genocea Biosciences, Inc. in 2018 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 8 increasing their positions, 14 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

17% less funds holding

Funds holding: 65 → 54 (-11)

21% less capital invested

Capital invested by funds: $56.4M → $44.5M (-$11.9M)

42% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 26

43% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 14

Holders
54
Holders Change
-11
Holders Change %
-16.92%
% of All Funds
1.24%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
15
Increased
8
Reduced
14
Closed
26
Calls
$1.3M
Puts
–
Net Calls
+$1.3M
Net Calls Change
-$278K

Top Buyers

Rank Fund Capital Flow
1
GTC
Ghost Tree Capital
New York
+$3.3M
2
Millennium Management
Millennium Management
New York
+$798K
3
PP
Paloma Partners
Connecticut
+$375K
4
BCM
BlueCrest Capital Management
Jersey
+$267K
5
BI
BVF Inc
California
+$248K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$3.48M
2
Northern Trust
Northern Trust
Illinois
-$616K
3
State Street
State Street
Massachusetts
-$565K
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$509K
5
TCIM
TIAA CREF Investment Management
New York
-$277K
Name Holding Trade Value Shares
Change 		Change in
Stake
CC
26
Centiva Capital
New York
$62K +$67.5K +9,029 New
California Public Employees Retirement System
27
California Public Employees Retirement System
California
$51K – – –
Deutsche Bank
28
Deutsche Bank
Germany
$50K -$215K -28,786 -80%
HighTower Advisors
29
HighTower Advisors
Illinois
$43K +$18.8K +2,513 +67%
Goldman Sachs
30
Goldman Sachs
New York
$34K +$14K +1,878 +63%
D.E. Shaw & Co
31
D.E. Shaw & Co
New York
$25K +$13.1K +1,757 +90%
State Street
32
State Street
Massachusetts
$23K -$565K -75,601 -96%
RE
33
RBC Europe
United Kingdom
$21.4K – – –
Bank of New York Mellon
34
Bank of New York Mellon
New York
$19K -$162K -21,674 -89%
Two Sigma Advisers
35
Two Sigma Advisers
New York
$19K +$8.02K +1,072 +63%
AA
36
AlphaMark Advisors
Kentucky
$17K – – –
Commonwealth Equity Services
37
Commonwealth Equity Services
Massachusetts
$15K +$232 +31 +1%
Invesco
38
Invesco
Georgia
$14K +$14.8K +1,979 New
Citigroup
39
Citigroup
New York
$11K -$9.91K -1,325 -45%
FANJ
40
Financial Architects (New Jersey)
New Jersey
$10K – – –
IA
41
IFP Advisors
Florida
$9K – – –
LPL Financial
42
LPL Financial
California
$9K +$9.55K +1,277 New
Wells Fargo
43
Wells Fargo
California
$8K -$12.1K -1,618 -57%
AWA
44
Artemis Wealth Advisors
New York
$7.78K – – –
Barclays
45
Barclays
United Kingdom
$4K -$11.9K -1,591 -75%
CFA
46
Carroll Financial Associates
North Carolina
$4K – – –
MAM
47
Meeder Asset Management
Ohio
$2.26K – – –
Federated Hermes
48
Federated Hermes
Pennsylvania
$2K – – –
TIM
49
Tortoise Investment Management
New York
$1K – – –
UBS Group
50
UBS Group
Switzerland
$1K +$1.17K +157 New
1
2
3 4

GNCA Hedge Fund Activity: Q2 2018 in Review

54 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Genocea Biosciences, Inc. (GNCA) for Q2 2018, worth a combined $44.5M — down 21% from $56.4M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of GNCA and 15 opened new positions — a net loss of 11 holders — while 14 trimmed existing stakes and 8 added.

The largest buyer was Ghost Tree Capital, opening a new position worth an estimated $3.3M. The largest seller was BlackRock, cutting an estimated $3.48M.

  • 54 institutional investors held Genocea Biosciences, Inc. (GNCA) as of Q2 2018, down from 65 in Q1 2018.
  • Funds reported $44.5M of Genocea Biosciences, Inc. stock for Q2 2018, down 21% quarter-over-quarter.
  • 15 funds opened new Genocea Biosciences, Inc. positions in Q2 2018 and 26 closed out, a net change of -11 holders.
  • The largest Genocea Biosciences, Inc. buyer in Q2 2018 was Ghost Tree Capital, an estimated $3.3M added.
  • The largest Genocea Biosciences, Inc. seller in Q2 2018 was BlackRock, an estimated $3.48M sold.

Based on aggregated 13F filings for Q2 2018.